Trump reversed a Biden order that sought to lower drug prices and make gene and cell therapies for cancer and other disease treatment available to Medicaid patients.

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

Essence Healthcare, a leading Medicare Advantage plan has received yet another year of above average Star ratings from the ...

Meena Seshamani believes the landmark Inflation Reduction Act will “lay the foundation” for future drug price negotiations ...

Moves by the incoming Trump Administration may be a boon to drugmakers, Novartis AG Chief Executive Officer Vas Narasimhan ...

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Billionaire investor Ken Griffin is the founder of Citadel Advisors, one of the world’s most successful alternative ...

As President Donald Trump begins his second term in the White House, the country faces several key fiscal policy deadlines ...

If the Coalition wants to head off a Mediscare campaign, Peter Dutton needs to acknowledge the Coalition's past attacks on ...

Medicare Advantage providers such as Louisville-based Humana Inc., saw tighter regulations over the last four years. We look ...

Curreen Capital Partners LP returned 5.71% for Q4 2024 and 7.72% for the year. Click here to read the full fund letter.

Clover Health Investments' AI technology and unique positioning in the healthcare market set them apart from competitors.